Taipei, Taiwan

Wen-Jeng Lee

This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Jeng Lee. Retrieved from https://idiyas.com/inventor/wen-jeng-lee-bnd5xyfk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cardiovascular Risk Prediction by Wen-Jeng Lee

Introduction

Wen-Jeng Lee is an accomplished inventor based in Taipei, Taiwan. He has made significant contributions to the field of cardiovascular health through his innovative patent. His work focuses on utilizing artificial intelligence to enhance cardiovascular risk prediction.

Latest Patents

Wen-Jeng Lee holds a patent titled "System and method for cardiovascular risk prediction and computer readable medium thereof." This invention provides a system and method for predicting cardiovascular risk by employing artificial intelligence to segment non-contrast or contrast medical images. The technology identifies precise regions of the heart, pericardium, and aorta, allowing for the derivation of adipose tissue volume and calcium score from medical images. This advancement assists healthcare professionals in making informed decisions regarding cardiovascular risk.

Career Highlights

Wen-Jeng Lee is affiliated with National Taiwan University, where he continues to contribute to research and innovation in the medical field. His expertise in artificial intelligence and medical imaging has positioned him as a key figure in cardiovascular research.

Collaborations

Wen-Jeng Lee collaborates with notable colleagues, including Tzung-Dau Wang and Yu-Cheng Huang. Their combined efforts in research and development further enhance the impact of their work in the medical community.

Conclusion

Wen-Jeng Lee's innovative approach to cardiovascular risk prediction exemplifies the intersection of technology and healthcare. His contributions are paving the way for improved patient outcomes and advancing the field of cardiovascular medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…